Balaxi Pharmaceuticals Ltd

NSE: BALAXI · Pharmaceuticals & Biotechnology · 17 announcements

Share price: ₹22.76
Market cap: ₹125.7 Cr
Revenue (annual): ₹270.2 Cr
Net profit (annual): ₹1.42 Cr
P/E (TTM): 51.8×Sector 47.4×
Promoter holding: 65.99%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 4 Earnings Call 2 Business Update 2 Board Meeting Date 2 Annual General Meeting 2 Results Correction 1 Price Movement Clarification 1 Other Announcement 1 Management Change 1 Board Meeting Outcome 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

9 Apr 2026 11:12 IST NSE

Price Movement Clarification

Balaxi Pharmaceuticals Price Movement Clarification

Balaxi Pharmaceuticals Limited clarified to the NSE that the recent significant movement in its share price is purely market-driven. The company confirmed there is no undisclosed material information or announcement that could impact price or volume behaviour, maintaining compliance with SEBI LODR regulations.

Read the filing ↗